Learning Objectives: After studying this article, the participant should be able to: 1. Understand the etiology and pathogenesis of the common conditions of craniofacial atrophy/hypoplasia and craniofacial neoplasia. 2. Recognize and classify craniofacial atrophy/hypoplasia and craniofacial neoplasia. 3. Understand the different management plans for the reconstruction of craniofacial conditions, including Romberg disease, postradiation hypoplasia, fibrous dysplasia, neurofibromatosis, and craniofacial tumors.
The spectrum of craniofacial malformations includes conditions of congenital and acquired etiology. The conditions of craniofacial atrophy and hypoplasia may arise primarily or secondary to previous therapeutic interventions. The conditions of progressive hemifacial atrophy (Romberg disease) and radiation-induced hypoplasia will be reviewed on the basis of their etiology, pathogenesis, anatomy, and treatment. Approaches to the surgical management of these conditions will be discussed. The craniofacial neoplastic conditions of fibrous dysplasia, neurofibromatosis, and craniofacial tumors will also be reviewed and discussed. (Plast. Reconstr. Surg. 111: 1497 Surg. 111: , 2003 Although the origin of craniofacial surgery arose from applications in the pediatric population, it also has wide indications in the adult population. Conditions that involve craniofacial atrophy and hypoplasia often require craniofacial reconstruction. The condition of progressive hemifacial atrophy (Romberg disease) presents with atrophy of skin, soft tissue, and bone. High-dose radiation is a standard form of treatment for some pediatric and adult craniofacial tumors, with subsequent development of soft-tissue and bony hypoplasia of the irradiated areas after treatment. The application of craniofacial surgical principles allows the correction of these similar problems arising in these very different conditions. Reconstructive principles encompass reconstruction of the craniofacial skeleton and the soft tissue.
The wide spectrum of craniofacial neoplasms includes fibrous dysplasia, simple osteomas, benign angiofibromas, and neural tumors. The two most common craniofacial tumors encountered by plastic surgeons are fibrous dysplasia and neurofibromatosis. An evolution from reconstructive craniofacial surgery is the application of craniofacial techniques to allow access to and ablation of such craniofacial neoplasms during an aesthetic reconstruction.
An overview of our current understanding of the etiology, assessment, and treatment of the conditions of progressive hemifacial atrophy (Romberg disease), radiation-induced atrophy, fibrous dysplasia, neurofibromatosis, and craniofacial neoplasms will be presented and discussed, as will the surgical correction of these craniofacial anomalies.
CONDITIONS OF CRANIOFACIAL
ATROPHY/HYPOPLASIA phy." The disease commences usually in the first or second decade of life and is more common in the female population, 4 with a femaleto-male ratio of 1.5 to 1. The atrophy is unilateral in 95 percent of cases. The right and left sides of the face are involved with equal frequency.
The cause of the disorder is unknown, although many theories as to its pathogenesis have been proposed. Foremost among these are infection, 5 trigeminal peripheral neuritis, 6 scleroderma, 4 and cervical sympathetic loss. 7 Pensler and colleagues 8 evaluated 41 patients and noted that in all patients the atrophic changes began in a localized area and progressed, at a variable rate, within the dermatome of one or more branches of the ipsilateral fifth cranial nerve. The average age at inception of the disease was 8.8 years, and the main period of progression was 8.9 Ϯ 6 years. In 26 patients with skeletal involvement, the mean age of onset was 5.4 years versus 15.4 years for 15 patients without skeletal involvement. No correlation could be established between severity of soft-tissue deformity and age of onset. Tissue from six patients who had ultrastructural analysis revealed a lymphocytic neurovasculitis with striking abnormalities of the vascular endothelium and basement membrane. The alterations of the vascular basal lamina of lymphocytic neurovasculitis seem to reflect chronic vascular damage with repeated attempts at endothelial cell regeneration (Fig.  1) .
In their series, Moore and colleagues 9 noted that 50 percent of patients had the classic early sign of coup de sabre, reflecting soft-tissue involvement in the upper face (frontal and maxillary dermatomes). In the presence of prolonged active disease, the soft-tissue atrophy extended to involve the whole hemiface. Cases of late-onset disease seem to be characterized by soft-tissue atrophy primarily involving the lower face. When bony hypoplasia is present, it predominately affects the middle and lower face, with involvement of the frontal region a relatively infrequent occurrence.
The derangement of the craniofacial skeleton that is seen is unlikely to be solely caused by an isolated intrinsic process. Moore et al. 9 surmise that the restriction imposed by the abnormal soft-tissue envelope undoubtedly compounds any primary skeletal growth disturbance. They conclude that if the disease process involves bone, it would seem to exert an effect on skeletal structure only during periods of facial growth acceleration. Treatment involves three-dimensional reconstruction of all soft-tissue and skeletal disturbances. The timing of operation is based on correction of the deformity after cessation of the ongoing atrophic process, usually at least 1 year after photographic monitoring records reveal no further progression of loss of volume to the face.
Soft-tissue reconstruction is directed at augmentation of deficient soft-tissue volume and involves a spectrum extending from fat injection to free tissue transfer. Past treatment methods have included silicone fluid injections, 10 which are contraindicated because of long-term complications, and injections of lipoaspirated fat, which have met with mixed results, 11 though autologous fat injections certainly have a place in the correction of mild contour irregularities. Muscular atrophy of pedicled or free muscle flaps presents a problem for calculating the final volume needed for the repair, 12 and for this reason adipose flaps are preferred.
When large-volume correction is necessitated, free tissue transfer is warranted. Greater omentum free flaps have been described by Jurkiewicz and Nahai, 13 who nevertheless point out the drawbacks of lack of structural strength and gravitational descent. Inigo and colleagues 14 review their experience with dermisfat free flaps in 35 patients with Romberg disease. They used a groin free flap in 33 patients and a scapular flap in three patients in a twostage procedure consisting of transfer of the free flap and defatting and repositioning 6 months later. Adjuvant procedures included temporal fascial flaps for the frontal regions and cartilage grafts in the piriform fossa. The chin was corrected by either sliding osteotomies for projections of less than 1 cm or by alloplastic implants for projections of more than 1 cm.
Dunkley and Stevenson 15 prefer a groin flap for soft-tissue augmentation because of its less conspicuous donor defect and lower potential morbidity. Tweed et al. 16 suggest that a smoother cheek contour can be achieved by placing the dermis outward. Harashina and Fujino 17 argue that placing the dermis side down should reduce gravitational sagging, one of the major problems with soft-tissue reconstruction in this situation. The abdominal flap, a variation of the groin flap based on the inferior epigastric vessels, has also been reported. 10, 18 Koshima et al. 19 describe their experience with the deep inferior epigastric perforator flap.
Mordick and colleagues 20 compared eight patients treated with dermal fat grafts and eight treated with vascularized tissue transfer to determine the efficacy of the two methods. The vascularized transfers provided a greater amount of augmentation. Dermal fat grafting was a satisfactory technique for mild-tomoderate defects. Dermal fat grafting is a shorter procedure requiring less anesthetic time, less technical expertise and support, and shorter hospital stays, whereas vascularized transfers that are composed of adipose tissue seem to increase in volume during growth and may also increase with weight gain. Late in their series, the authors lean toward augmentation with the scapular flap because of its large-caliber vessels and long pedicle. Their patients averaged 3.3 procedures for final correction.
Upton and colleagues 21 reported their experience with 30 scapular flaps for cheek reconstruction. Five of these patients had Romberg disease. The major advantages of the scapular flap included a constant proximal vascular anatomy, a long vascular pedicle with largecaliber vessels, a large amount of available tissue (including bone), relatively hairless skin in most patients, and minimal or no functional problems at the donor site. Major disadvantages included lack of sensation, poor external cheek skin color match, and a predictably widened scar at the donor site. The study produced the following observations:
Deficiency of the malar prominence cannot always be corrected with soft tissue alone and often needs bone grafting or alloplastic implant.
Correction with extensor fascial hypertrophy-long fascial extension must be transferred across the midline of the upper and lower lips.
The area most consistently uncorrected is the medial portions of the deficient upper and lower lips.
The area most consistently overcorrected overlies the mandibular body and ramus.
Longaker and Siebert 22 reported their experience with 15 cases of Romberg disease representing 16 free tissue transfers. Deepithelialized extended parascapular flaps with large fascial extensions of the dorsal thoracic fascia were used for reconstruction. The fascia can be folded into variable thicknesses to correct subtle contour defects of the upper lip, medial canthus, eyelids, and other facial features traditionally difficult to reconstruct. These exten-sions can be placed easily across the midline to interdigitate with normal tissues at the boundary of the facial deformity.
Severe cases with bone involvement require orthognathic surgery in addition to all of the above procedures. A Le Fort I osteotomy can be performed to lengthen the maxilla and improve the vertical dimension of the face on the affected side. A sagittal split osteotomy can be performed to complete the required rotationprojection of the mandible in association with an advancement or sliding genioplasty (Fig. 2) .
Radiation-Induced Craniofacial Deformity
High-dose radiation is a standard form of treatment for some pediatric craniofacial tumors, including retinoblastoma, rhabdomyosarcoma, Ewing sarcoma, and neurofibrosarcoma. It also has application in the treatment of oropharyngeal carcinoma in adults. After radiation treatment, patients can subsequently develop soft-tissue and bony hypoplasia of the irradiated areas. These deficiencies can be partially corrected by onlay bone grafting and softtissue reconstruction with local pedicled flaps and dermal-fat grafts in multiple stages, 23 or they may necessitate free tissue transfer (Fig.  3 ).
Jackson and colleagues 24 studied 14 children who received therapeutic radiation for malignant tumors in the orbital area and who subsequently showed widespread craniofacial deformities. The original tumors were retinoblastoma, rhabdomyosarcoma, and embryonic carcinoma. Years later, maldevelopment of the skull, orbit, maxilla, and mandible became apparent. Jackson et al. 24 recommend the correction of four levels of skeletal deformity in a single procedure, as follows:
1. frontotemporal expansion with repositioning of the cranial base 2. orbital expansion and repositioning 3. maxillary surgery with bone grafts to the zygoma as required 4. mandibular lengthening and repositioning Bone grafts should be inlay rather than onlay, and soft tissue should be supplied by free tissue transfer. At a second operation, the eye socket and eyelids are reconstructed to allow more satisfactory rehabilitation with an ocular prosthesis. Based on their observations during extensive skull base and orbital dissections, Jackson and colleagues 24 believe that radiation has impaired the growth of the sphenoid, which in turn has locked the upper face and prevented normal development of the facial skeleton. In addition, the frontal, ethmoid, and maxillary sinuses have failed to expand, resulting in a further decrease of craniofacial 
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PLASTIC AND RECONSTRUCTIVE SURGERY, April 1, 2003 dimensions. Craniotomy is essential to position the skull base correctly to accurately seat and remodel the orbit and maxilla. Similar procedures and approaches to correction of these deformities have been described by Nwoku and Koch, 25 Larson, 26 Marx and Johnson, 27 Guyuron and colleagues, 28, 29 and Kawamoto. 30 Cohen et al. 23 described their experience with reconstruction of late craniofacial deformities after therapeutic radiation of the head and face during childhood. Forty percent of the patients in their series required secondary procedures for improvement. The authors anticipate increasing the use of free tissue transfer in these cases.
Individuals who as children were irradiated for hemangiomas of the face are also presenting to plastic surgery clinics with severe craniofacial deformities. At one time, high-beam radiotherapy was advocated for capillary hemangioma of the cheek. The sequelae of this treatment in the growing child are now painfully evident as severe facial deformities in the adult. Reconstruction should follow the principles outlined by Jackson and colleagues 24 ( Fig. 4) .
CRANIOFACIAL NEOPLASMS

Fibrous Dysplasia
The most common osseous craniofacial tumor encountered by plastic surgeons is fibrous dysplasia. 23 an uncommon, non-neoplastic, benign bone disease first described by von Recklinghausen in 1891. 31 The pathogenesis of fibrous dysplasia involves abnormal activity of the bone-forming mesenchyme with an arrest of bone maturation in the woven bone stage, forming irregularly shaped trabecula. Mutations of signaling protein and increased interleukin-6 levels have been implicated in the process. 32 The condition is usually progressive until age 30, and reports of progression well into adulthood are not uncommon. 32 Fibrous dysplasia in the cranio-orbital area tends to be more osseous than fibrous dysplasia of other sites. Two patterns of presentation predominate: the monostotic form, with singlebone involvement, and the polyostotic variety, which may be associated with abnormal skin pigmentation, premature sexual development, and hyperthyroidism (Albright syndrome). The monostotic form is approximately four times more common than the polyostotic form and approximately 30 times more frequent than the complete Albright syndrome. The monostotic form typically involves the ribs, femur, tibia, cranium, maxilla, and mandible. The most often affected bones in the cranium are the frontal and sphenoid bone, and in the face, the maxilla. he believes are the keys to its effective management:
Deformation caused by fibrous dysplasia of the anterior skull base can affect the architecture of the orbits and paranasal sinus, causing orbital displacement and exophthalmos. 35, 36 In craniofacial fibrous dysplasia, the symptoms are varied and related to tumor mass. Symptoms may include facial pain and swelling, headaches, anosmia, deafness, blindness, malocclusion with displacement of teeth, diplopia, proptosis, and orbital dystopia. Cranial nerve palsies including optic nerve compression are not uncommon. 37 Eye symptoms may include extraocular muscle palsy and trigeminal neuralgia secondary to compression of the third and fifth cranial nerves. Orbital apex compression can initiate the cascade of ophthalmic venous engorgement, optic nerve atrophy, and loss of vision. Sphenoid body involvement can cause blindness as a result of compression of the optic nerve between the chiasm and optic foramen. Minor ophthalmic symptoms include epiphora produced by occlusion of the lacrimal duct and visible external lid deformities. 38 Malignant degeneration occurs in approximately 0.5 percent of patients. 39 Clinical signs of malignancy consist of a rapid increase in size, pain, intralesional necrosis, bleeding, and elevation of serum alkaline phosphatase levels. The most common transformation is to osteogenic sarcoma, but fibrosarcoma and chondrosarcoma are also seen. The mean interval from diagnosis of fibrous dysplasia to evidence of malignancy is 13.5 years. 38 The polyostotic form of the disease has a higher incidence of malignant degeneration, although the monostotic form is more common in the craniofacial region. Malignant degeneration can occur spontaneously or following radiotherapy.
Familial fibrous dysplasia or cherubism is a genetic disorder of the mandible and maxilla of the giant-cell type. It is strictly a self-limiting disease of children that regresses without operation and leaves no deformity. 40 In the past, conservative treatment of fibrous dysplasia was preferred, occasionally with bonecontouring procedures. Spontaneous involution will not occur, however, and early surgical intervention when symptoms are just beginning may avoid extensive resection later. 41 When clinically feasible, the mainstay of therapy is complete or near-complete resection and reconstruction with normal autogenous bone. In 1972, Derome 42 pioneered the concept of total excision and immediate reconstruction of bone tumors, including four cases of fibrous dysplasia. Chen and colleagues 43 discussed the benefits and risks of prophylactic optic nerve decompression before symptoms develop. The decision for operation in these cases is made solely on the basis of computed tomographic findings of encroachment of the optic canal by fibrous dysplasia. The primary justification for prophylactic decompression is the speed with which visual deterioration can occur and the short span of time before it becomes permanent. Among the reports of sudden loss of vision, several attribute the cause of blindness to hemorrhage or mucocele secondary to fibrous dysplasia. 44 In their own study of 18 patients with clinical or radiological evidence of optic canal involvement, Chen and associates 43 found that six patients (33 percent) had loss of effective vision in the involved eye. From this experience and a review of the literature, the authors developed an algorithm for decompression of the optic nerve in fibrous dysplasia. Absolute indications for decompression are:
• progressive gradual visual loss • presentation within 1 week of sudden visual loss Relative indications for decompression are:
• presentation within 2 to 3 weeks of rapid visual loss • children or adolescents presenting with no visual loss but radiographic evidence of optic canal reduction, because of the likelihood of progressive growth of fibrous dysplasia • adults presenting with no visual loss but radiographic evidence of optic canal reduction and continuing, active fibrous dysplasia (Fig. 5) Reconstruction after resection is typically immediate. Edgerton and colleagues 31 described the use of the dysplastic bone as grafts, which, after resection, were contoured, thinned, and replaced. These grafts of dysplastic bone seem 1502 PLASTIC AND RECONSTRUCTIVE SURGERY, April 1, 2003 to function similarly to normal autogenous grafts, and they lack the potential for the gradual recurrence of bone thickening frequently seen with in situ bone contouring. Autoclaving 45 and cryotherapy 46, 47 have been proposed to destroy the cellular elements and yet preserve the mineral matrix before reinsertion.
Chen and Noordhoff 48 analyzed their experience with the treatment of 28 patients with fibrous dysplasia. The authors outline an operating protocol that includes:
• total excision of dysplastic bone of the frontoorbital, zygomatic, and upper maxillary region and primary reconstruction with bone grafts • conservative excision of bone from under the hair-bearing skull, central cranial base, and tooth-bearing regions • optic canal decompression in patients with orbital involvement and decreasing visual acuity (Fig. 6) In a follow-up averaging 5.3 years, the authors found no recurrence or invasion of fibrous dysplasia into the grafted bone; however, five of 19 patients treated with reduction of alveolar dysplasia had recurrence of the deformity that necessitated reshaping. One patient with recurrent mandibular fibrous dysplasia was successfully treated with hemimandibulectomy and mandibular reconstruction with vascularized bone graft.
Hansen-Knarhoi and Poole 49 remarked on the difficulty of differentiating fibrous dysplasia from intraosseous meningioma around the orbital apex. From a review of their files, they summarized the differences as follows:
• Fibrous dysplasia commences in childhood and early adolescence, whereas meningiomas are diseases of middle age.
• Visual symptoms are prominent in meningioma cases but are uncommon in fibrous dysplasia.
• Proptosis is much more marked than orbital dystopia in the meningioma group, but the reverse is true in fibrous dysplasia.
• Fibrous dysplasia patients have extensive frontal bone involvement that is clinically obvious; meningioma patients have no evidence of this.
• Pain is present in both groups and is not a useful discriminating feature.
Most fibrous dysplasia lesions can be only partly excised. Some are unresectable, arguing for treatment methods other than operation. No medical treatment is available to cure or definitively halt the progression of fibrous dysplasia. Reports of promising responses to systemic treatments with the biphosphate pamidronate await further studies before conclusions can be drawn. 50 Clark et al. 51 implanted fibrous dysplasia cells in a nude mouse model and successfully decreased the size of the tumor with tamoxifen administration (Fig. 7) .
Neurofibromatosis
Neurofibromatosis is a hereditary condition occurring in one in 3000 live births. The term Neurofibromatosis is a benign tumor of neuroectodermal origin with diffusion to skin, subcutaneous tissue, and bone. Tumor growth is slow and irregular and is not accelerated by surgical intervention, with sarcomatous degeneration a rare occurrence.
Surgical care often produces less than complete correction with some further progression over time. 53, 54 Poole, 53 in a series of 11 patients, stressed the high complication rate and the modest improvement in appearance that should be expected. The best cosmetic results are obtained in patients whose eye can be removed and a satisfactory bed created for an orbital prosthesis. Patients who have vision in the eye and wish to retain it should undergo a two-stage procedure with conservative debulking of intraorbital soft tissue. Krastinova-Lolov and Hamza 52 reviewed their experience with 14 cases of cranio-orbital neurofibromatosis. They noted that the partial or complete absence of the greater wing of the sphenoid is responsible for enlargement of the sphenoidal fissure, with a consequent defect in the posterior wall of the orbit. Brain tissue, generally the temporal lobe, may herniate into the orbit, further increasing exorbitism and causing pulsation of the eye. The orbit is enlarged, with hypoplasia of the supraorbital and infraorbital rims and the zygomatic arch. When the globe is involved with the neurofibroma, there may be buphthalmos, severely diminished visual acuity, and even blindness. Associated symptoms are irritation, pain in the eye, and moderate-to-severe epiphora. Enophthalmos may occur from enlargement of the inferior orbital fissure, which allows the orbital contents to prolapse into the infratemporal fossa and increases the size of the orbital cavity.
Snyder et al. 55 described the experience of the Australian Craniofacial Unit in correcting 14 cases of orbital neurofibromatosis. Of note was their finding of resorption of the bone graft used to reconstruct the greater wing of the sphenoid in four cases, which led to recurrence of globe pulsation. Subsequently, the authors began using titanium mesh in the reconstruction. Jackson et al. 56 presented their experience with orbitotemporal neurofibromatosis in 24 patients and provided a classification and treatment scheme. They grouped the condition into three categories, each of which requires a different treatment: (1) orbital softtissue involvement with vision in the eye, (2) orbital soft-tissue and significant bone involvement with vision in the eye, and (3) orbital soft-tissue and significant bone involvement with a blind or absent eye (Fig. 8) . In addition, the authors reported their follow-up observations over a 12-year period.
Craniofacial Tumors
Many different kinds of neoplasms can potentially involve the craniofacial skeleton, including fibrous dysplasia, simple osteomas; benign angiofibromas; neural tumors, specifically, meningiomas with extracranial erosion and encapsulated neurofibromas, schwannomas, and neurilemmomas [57] [58] [59] ; cutaneous carcinomas; osteogenic sarcomas; and rhabdomyosarcomas.
The use of craniofacial techniques in the ablation of craniofacial tumors arose from the evolving application of such techniques in congenital craniofacial conditions. As clinical experience mounted, the following principles for the surgical management of craniofacial neoplasms evolved:
It is now possible to resect lesions that were previously considered unresectable. 60 Tumor position should be related to the base of the skull. 61 Tumor resection demands strict adherence to guidelines designed for tumor location, cell type, and stage, and the concept of complete en bloc excision. The latter is possible through regional orbitotomies for confined orbital tumors, bifrontal craniotomy, and facial incisions (e.g., Weber-Ferguson) when necessary.
There is a significant risk of losing the frontal bone flap to infection. 62, 63 The transfacial approach 64 may reduce the frequency of infectious complications.
It is essential to prevent communication be- tween the sinuses or nasal cavity and the meninges or intracranial dead space. The best way to achieve this is by interposing thin, vascularized tissue, such as a pedicled paracranial flap for very small defects, a galea frontalis flap for anterior defects, 65 and a temporalis muscle 66 or temporoparietalis fascial flap for lateral and central defects.
The tissue that isolates the intracranial contents can also be supplied by a microsurgical free flap. 67, 68 In addition to preventing communication with the oral cavity and nasopharynx, free flaps offer protection for vital structures and bring large amounts of soft-tissue bulk for contouring. These flaps can be transferred secondarily to treat complications, but they probably should be raised prophylactically at the time of the ablative procedure. A 1989 survey 69 showed the use of primary free flaps in as many as 50 percent of cases of intracranial tumors.
Lund and colleagues 70 reviewed the results of treatment in 209 patients with craniofacial tumors with up to 17 years of follow-up. Malignant conditions predominated (68 percent), the most common of which was adenocarcinoma, although 41 different pathological findings were encountered. Nasal obstruction (55 percent) and epistaxis (38 percent) were the most common presenting symptoms; orbital symptoms were manifest in 56 percent of patients. Resection involved a craniofacial approach, with a frozen section used to ascertain involvement of the orbit necessitating resection. No orbital resection was necessary in 69 percent of the patients. In 11 percent, the orbital periosteum was removed and the globe was preserved based on the results of the intraoperative frozen section; 20 percent of the patients had orbital clearance, and 80 percent showed no dural involvement. Survival using this approach was 51 percent at 5 years and 41 percent at 10 years. In a precraniofacial era, survival results of 23 percent to 38 percent were expected. 70 The authors provide an algorithm for approaching such problems.
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